Both in Pharmaceuticals
Arvinas vs Faeth Therapeutics
Over the past year ARVN returned −7.0% and FTH returned −50.1%; their daily moves had a correlation of 0.63.
ARVN −7.0% FTH −50.1%Growth of $1, one year, split-adjusted
| Metric | ARVN | FTH |
|---|---|---|
| Price | $7.86 | $18.69 |
| Market cap | $513.9M | $483.0M |
| Today | −0.51% | −0.32% |
| 1 month | +5.8% | −33.9% |
| 6 months | −25.2% | — |
| Year to date | −33.7% | — |
| 1 year | −18.0% | — |
| Revenue growth (YoY) | +1014.7% | — |
| Gross margin | 96.4% | — |
| Net margin | 67.8% | — |
| P/E (TTM) | 55.3× | — |
| Price / sales | 1.6× | — |
| Net cash | $567.6M | $186.4M |
| Dividend yield | — | — |
| Volatility (60d) | 46.6% | — |
| Short % of float | 10.2% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).